← Back to all stories
Nose Spray Vaccine Shows Promise in Fight Against Tuberculosis
Photo: CDC / Unsplash
Researchers at Johns Hopkins Medicine are advancing a groundbreaking nasal vaccine designed to combat tuberculosis, the world's deadliest infectious disease. By combining two TB genes, the vaccine aims to train the immune system to eliminate drug-resistant bacteria that survive standard antibiotic treatment, offering hope for improved TB control globally.
Researchers at Johns Hopkins Medicine are advancing a groundbreaking nasal vaccine designed to combat tuberculosis, the world’s deadliest infectious disease. By combining two TB genes, the vaccine aims to train the immune system to eliminate drug-resistant bacteria that survive standard antibiotic treatment, offering hope for improved TB control globally.